 
				 
										
USFDA APPLICATION NUMBER - 202342 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 24.65MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength | 
|---|---|---|
| ESOMEPRAZOLE STRONTIUM(UNII: C5N25H3803) (ESOMEPRAZOLE - UNII:N3PA6559FT) | ESOMEPRAZOLE | 24.65mg | 49.3mg | 
Inactive Ingredients
| Ingredient Name | ParaPRO LLC | 
|---|---|
| CALCIUM CARBONATE(H0G9379FGK) | |
| FD&C BLUE NO. 1(H3R47K3TBD) | |
| FD&C RED NO. 40(WZB9127XOA) | |
| FD&C YELLOW NO. 6(H77VEI93A8) | |
| GELATIN(2G86QN327L) | |
| GLYCERYL MONOSTEARATE(230OU9XXE4) | |
| HYPROMELLOSES(3NXW29V3WO) | |
| METHACRYLIC ACID(1CS02G8656) | |
| POLYSORBATE 80(6OZP39ZG8H) | |
| STARCH, CORN(O8232NY3SJ) | |
| SUCROSE(C151H8M554) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIETHYL CITRATE(8Z96QXD6UM) |